Cargando…

Understanding immune perspectives and options for the use of checkpoint immunotherapy in HCC post liver transplant

Treatment modalities for hepatocellular carcinoma (HCC) vary from surgical techniques and interventional radiologic strategies to systemic therapy. For the latter, the use of immune checkpoint inhibitors (ICIs) has gained popularity due to successful trials showing increased survival. In patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anugwom, Chimaobi M., Leventhal, Thomas M., Debes, Jose D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181209/ https://www.ncbi.nlm.nih.gov/pubmed/35693455 http://dx.doi.org/10.20517/2394-5079.2021.123

Ejemplares similares

Nivolumab-Induced Autoimmune-Like Cholestatic Hepatitis in a Liver Transplant Recipient
por: Anugwom, Chimaobi, et al.
Publicado: (2020)

Systematic analysis of acute liver injury during SARS-CoV-2 infection
por: Debes, Jose D., et al.
Publicado: (2020)

Inverse Association Between Chronic Hepatitis B Infection and Coronavirus Disease 2019 (COVID-19): Immune Exhaustion or Coincidence?
por: Anugwom, Chimaobi M, et al.
Publicado: (2020)

Thyroid Disease–Induced Hepatic Dysfunction: A Clinical Puzzle
por: Anugwom, Chimaobi M., et al.
Publicado: (2021)

L-Asparaginase-Induced Hepatotoxicity Treated Successfully With L-Carnitine and Vitamin B Infusion
por: Lee, Christina, et al.
Publicado: (2021)

Protein-losing Enteropathy Due to Inferior Vena Cava Stenosis in a Liver Transplant Recipient
por: Anugwom, Chimaobi M., et al.
Publicado: (2021)

A Case of Infiltrative Hepatocellular Carcinoma With Vascular Invasion Into the Heart
por: Anugwom, Chimaobi M, et al.
Publicado: (2021)

Hepatocellular carcinoma in Hepatitis B and Human Immunodeficiency Virus coinfection in Africa: a focus on surveillance
por: Wan, Qian, et al.
Publicado: (2022)

The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma
por: Rico Montanari, Noe, et al.
Publicado: (2021)

Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology
por: Anugwom, Chimaobi M., et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in the Treatment of HCC
por: Donisi, Clelia, et al.
Publicado: (2021)

Hepatitis E virus infection in the United States: Seroprevalence, risk factors and the influence of immunological assays
por: Pisano, María Belén, et al.
Publicado: (2022)

Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint Blockade
por: Gorzo, Alecsandra, et al.
Publicado: (2022)

Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC
por: Marzi, Luca, et al.
Publicado: (2022)

The Treatment Effect of Liver Transplantation versus Liver Resection for HCC: A Review and Future Perspectives
por: Beumer, Berend R., et al.
Publicado: (2021)

Case of Primary Hepatic Angiosarcoma Presenting With Jaundice and Infiltrative Liver Masses
por: Shaaban, Adnan, et al.
Publicado: (2022)

Vanishing Bile Duct Syndrome Preceding the Diagnosis of Hodgkin Lymphoma
por: Anugwom, Chimaobi, et al.
Publicado: (2020)

Challenges of the Immunotherapy: Perspectives and Limitations of the Immune Checkpoint Inhibitor Treatment
por: Dobosz, Paula, et al.
Publicado: (2022)

CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment
por: Han, Rui, et al.
Publicado: (2023)

Circulating Cytokines Reflect the Etiology-Specific Immune Environment in Cirrhosis and HCC
por: Beudeker, Boris J. B., et al.
Publicado: (2022)

The paradox of immunotherapy in NASH-HCC
por: Peng, Yao, et al.
Publicado: (2021)

Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation
por: Crocetti, Laura, et al.
Publicado: (2021)

Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?
por: Jiang, Jingyu, et al.
Publicado: (2023)

Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
por: Sharma, Rohini, et al.
Publicado: (2022)

Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade
por: Shu, Daniel H., et al.
Publicado: (2023)

Aceruloplasminemia: A Case Report and Review of a Rare and Misunderstood Disorder of Iron Accumulation
por: Anugwom, Chimaobi M, et al.
Publicado: (2020)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
por: Bicer, Fuat, et al.
Publicado: (2023)

Radiological‐histopathological discordance in patients transplanted for HCC and its impact on post‐transplant outcomes
por: Mohamed, Islam B., et al.
Publicado: (2023)

AFP ratio predicts HCC recurrence after liver transplantation
por: Koch, Christine, et al.
Publicado: (2020)

The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors
por: Zhang, Lilong, et al.
Publicado: (2022)

Immune checkpoints and immunotherapy for colorectal cancer
por: Singh, Preet Paul, et al.
Publicado: (2015)

Immune checkpoint signaling and cancer immunotherapy
por: He, Xing, et al.
Publicado: (2020)

Diversity of immune checkpoints in cancer immunotherapy
por: Guo, Zhangyan, et al.
Publicado: (2023)

Immune checkpoint inhibitors in liver transplant: a case series
por: Rudolph, Mark, et al.
Publicado: (2023)

Peripheral blood CD4(+) cell ATP activity measurement to predict HCC recurrence post‐DCD liver transplant
por: Zhang, W., et al.
Publicado: (2016)

Cutaneous Toxicities of Immune Checkpoint Inhibitors: The Role of the Dermatologist
por: Tattersall, Ian William, et al.
Publicado: (2020)

HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation
por: Emamaullee, Juliet A., et al.
Publicado: (2019)

Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach
por: Mazzaferro, Vincenzo
Publicado: (2016)

Human Cytomegalovirus Is Associated with Lower HCC Recurrence in Liver Transplant Patients
por: Hsu, Po-Jung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0unhkrp9036s2ipau0e0rq0b0v